In an article published in the May 2025 edition of the CPI Antitrust Chronicle, Partner Nana Wilberforce and Counsel John O’Toole and Sarah Pugh offer predictions about the areas incoming regulators may prioritize in their antitrust enforcement agendas for healthcare.
Excerpt: “The newly installed Trump Administration is poised to continue focus on antitrust enforcement in healthcare markets. FTC Chair Andrew Ferguson has stated that healthcare is one of his top enforcement priorities, and DOJ Assistant Attorney General Gail Slater referred to healthcare competition as a “critical priority” during her confirmation hearings. The FTC has already made good on its word by challenging the acquisition of a medical device company by a private equity firm. Beyond federal enforcers, state AGs are also likely to remain active in the healthcare space, particularly in “blue” states that might perceive federal antitrust enforcement as too insufficient.”
